Article in valneva
-
FDA Approves World’s First Chikungunya Vaccine- Valneva’s Single Dose IXCHIQ
IXCHIQ has received the approval of the United States Food and Drug Administration (US FDA) for use in adults who are 18 years and older.
IXCHIQ has received the approval of the United States Food and Drug Administration (US FDA) for use in adults who are 18 years and older.